Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 2/20 | 0.62 |
| ▸ | P2RY12 | Q9H244 | 4/20 | 0.57 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.49 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.48 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.48 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.48 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.48 |
| ▸ | CXCR3 | P49682 | 5/20 | 0.48 |
| ▸ | SMO | Q99835 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13930613 | 1.00 | SLC2A1 (0.62) | SLC2A1P2RY12MALT1MAPTLMNA | |
| SCHEMBL13930706 | 0.88 | P2RY12 (0.60) | SLC2A1P2RY12MAPTCHRNB2CHRNB4 | |
| SCHEMBL31107153 | 0.88 | P2RY12 (0.60) | SLC2A1P2RY12MAPTCHRNB2CHRNB4 | |
| SCHEMBL3677907 | 0.88 | SLC2A1 (0.68) | SLC2A1P2RY12MALT1LMNAMAOB | |
| SCHEMBL3687374 | 0.88 | SLC2A1 (0.68) | SLC2A1P2RY12MALT1MAPTLMNA | |
| SCHEMBL4258257 | 0.87 | SLC2A1 (0.67) | SLC2A1P2RY12MALT1MAPTLMNA | |
| SCHEMBL13930624 | 0.87 | SLC2A1 (0.67) | SLC2A1P2RY12MALT1MAPTLMNA | |
| SCHEMBL31107157 | 0.87 | SLC2A1 (0.67) | SLC2A1P2RY12MALT1MAPTLMNA | |
| SCHEMBL4252921 | 0.85 | SLC2A1 (0.67) | SLC2A1P2RY12MALT1MAPTLMNA | |
| SCHEMBL3683318 | 0.85 | SLC2A1 (0.65) | SLC2A1P2RY12MALT1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240307361-A1 | METHOD FOR DIAGNOSING AND TREATING IRRITABLE BOWEL SYNDROME | Centre for Chinese Herbal Medicine Drug Development Limited (CN) | 2024-09-19 | — | — | US | disclosed |
| US-20240295566-A1 | METHOD FOR DIAGNOSING AND TREATING METABOLIC DISORDERS | Centre for Chinese Herbal Medicine Drug Development Limited (CN) | 2024-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240307361-A1 | METHOD FOR DIAGNOSING AND TREATING IRRITABLE BOWEL SYNDROME | HRH4, VIPR1, TAAR1 | SLC2A1 1885/4885P2RY12 1169/4885MALT1 1602/4885 |
| US-20240295566-A1 | METHOD FOR DIAGNOSING AND TREATING METABOLIC DISORDERS | TPH1, GPR119, TAAR1 | SLC2A1 130/4885P2RY12 1964/4885MALT1 2629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.